UPDATE 1- FDA panel recommends approval for Amgen's skin cancer immunotherapy

April 29 (Reuters) - Amgen Inc's skin cancer immunotherapy showed enough efficacy in the treatment of melanoma to be given marketing approval, an independent advisory panel to the U.S. Food and Drug Administration said on Wednesday.